{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\" and docket_id = \"FDA-2008-P-0411\" sorted by posted_date descending", "rows": [["FDA-2008-P-0411-0021", "FDA", "FDA-2008-P-0411", "FDA Office of Policy to Novo Nordisk, Inc. - Petition Reconsideration & Petition for Stay of Action Denial", "Other", "PDN-Petition Denial", "2009-06-18T04:00:00Z", 2009, 6, "2009-06-18T04:00:00Z", null, "2013-07-27T22:47:20Z", null, 0, 0, "09000064809d2328"], ["FDA-2008-P-0411-0018", "FDA", "FDA-2008-P-0411", "Exhibit 1 - \"Caraco Letter to FDA/CDER , re: ANDA 77-571/Repaglinide, May 29, 2009\" - [Caraco Pharmaceuticals Laboratories, LTD - (Winston & Strawn LLP) - Reply Comment] re FDA-2008-P-0411-0017", "Supporting & Related Material", "RC-Reply Comment (Supporting and Related Material)", "2009-06-17T04:00:00Z", 2009, 6, null, null, "2009-06-18T00:15:06Z", null, 0, 0, "09000064809d05f7"], ["FDA-2008-P-0411-0020", "FDA", "FDA-2008-P-0411", "Exhibit 3 - \"Caraco's Motion and Brief in Support of Motion Requesting Leave to Supplement Answer and CounterClaims, Civil Action No. 2:05 CV 40188\" - [Caraco Pharmaceuticals Laboratories, LTD - (Winston & Strawn LLP) - Reply Comment] re FDA-2008-P-0411-0017", "Supporting & Related Material", "RC-Reply Comment (Supporting and Related Material)", "2009-06-17T04:00:00Z", 2009, 6, null, null, "2009-06-18T00:16:16Z", null, 0, 0, "09000064809d05fc"], ["FDA-2008-P-0411-0019", "FDA", "FDA-2008-P-0411", "Exhibit 2 - \"Winston & Strawn LLP (on behalf of Caraco) to FDA/CDER, re: request for Correction, June 1, 2009\" - [Caraco Pharmaceuticals Laboratories, LTD - (Winston & Strawn LLP) - Reply Comment] re FDA-2008-P-0411-0017", "Supporting & Related Material", "RC-Reply Comment (Supporting and Related Material)", "2009-06-17T04:00:00Z", 2009, 6, null, null, "2009-06-18T00:15:29Z", null, 0, 0, "09000064809d05fb"], ["FDA-2008-P-0411-0009", "FDA", "FDA-2008-P-0411", "Novo Nordisk Inc. - Petition for Stay of Action", "Other", "PSA-Petition for Stay", "2008-12-31T05:00:00Z", 2008, 12, "2008-12-31T05:00:00Z", null, "2013-08-11T02:58:51Z", null, 0, 0, "09000064807f9170"], ["FDA-2008-P-0411-0007", "FDA", "FDA-2008-P-0411", "Novo Nordisk Inc. - Petition for Reconsideration", "Other", "PRC-Petition for Reconsideration", "2008-12-31T05:00:00Z", 2008, 12, "2008-12-31T05:00:00Z", null, "2009-06-18T16:54:55Z", null, 0, 0, "09000064807f8de8"], ["FDA-2008-P-0411-0010", "FDA", "FDA-2008-P-0411", "Acknowledgement Letter to Novo Nordisk Inc.", "Other", "ACK-Acknowledgement Letter", "2008-12-31T05:00:00Z", 2008, 12, "2008-12-31T05:00:00Z", null, "2013-07-28T01:58:06Z", null, 0, 0, "09000064807f8e2e"], ["FDA-2008-P-0411-0008", "FDA", "FDA-2008-P-0411", "Acknowledgement Letter to Novo Nordisk Inc.", "Other", "ACK-Acknowledgement Letter", "2008-12-31T05:00:00Z", 2008, 12, "2008-12-31T05:00:00Z", null, "2013-07-27T22:34:27Z", null, 0, 0, "09000064807f919e"], ["FDA-2008-P-0411-0006", "FDA", "FDA-2008-P-0411", "FDA/CDER to Caraco Pharmaceuticals Laboratories, Ltd. (James F. Hurst) - Petition Approval", "Other", "PAV-Petition Approval", "2008-12-04T05:00:00Z", 2008, 12, "2008-12-04T05:00:00Z", null, "2009-01-23T15:55:32Z", null, 0, 0, "09000064807cd3e5"], ["FDA-2008-P-0411-0003", "FDA", "FDA-2008-P-0411", "Caraco Pharmaceutical Laboratories, Ltd - Amendment", "Other", "AMD-Amendment", "2008-08-05T04:00:00Z", 2008, 8, "2008-08-05T04:00:00Z", null, "2013-07-27T22:20:54Z", null, 0, 0, "09000064806af9aa"], ["FDA-2008-P-0411-0002", "FDA", "FDA-2008-P-0411", "Acknowledgement Letter to Caraco Pharmaceutical Laboratories, Ltd.", "Other", "ACK-Acknowledgement Letter", "2008-07-20T04:00:00Z", 2008, 7, "2008-07-20T04:00:00Z", null, "2008-11-17T19:26:29Z", null, 0, 0, "090000648067e39c"], ["FDA-2008-P-0411-0001", "FDA", "FDA-2008-P-0411", "Caraco Pharmaceutical Laboratories, Ltd. -  Citizen Petition", "Other", "CP-Citizen Petition", "2008-07-20T04:00:00Z", 2008, 7, "2008-07-20T04:00:00Z", null, "2009-05-01T21:55:41Z", null, 0, 0, "090000648067e350"]], "truncated": false, "filtered_table_rows_count": 12, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"docket_id\" = :p1 order by posted_date desc limit 101", "params": {"p0": "FDA", "p1": "FDA-2008-P-0411"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-P-0411", "results": [{"value": "FDA", "label": "FDA", "count": 12, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2008-P-0411", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-P-0411", "results": [{"value": "Other", "label": "Other", "count": 9, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-P-0411&document_type=Other", "selected": false}, {"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 3, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-P-0411&document_type=Supporting+%26+Related+Material", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-P-0411", "results": [{"value": 2008, "label": 2008, "count": 8, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-P-0411&posted_year=2008", "selected": false}, {"value": 2009, "label": 2009, "count": 4, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-P-0411&posted_year=2009", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "title", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-P-0411&_facet=title"}, {"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-P-0411&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-P-0411&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-P-0411&_facet=posted_month"}, {"name": "comment_start_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-P-0411&_facet=comment_start_date"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-P-0411&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-P-0411&_facet_date=comment_start_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-P-0411&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 943.1160798994824, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}